CC BY 4.0 · Arq Neuropsiquiatr 2024; 82(S 02): S53-S176
DOI: 10.1055/s-0045-1806977
ID: 553
Area: Cerebrovascular diseases and intensive care in child neurology
Presentation method: Eletronic Poster

Recurrent stroke in a 5-year-old child with Moyamoya disease: a case report

Jessica Ariane Silva Valverde
1   Universidade do Vale do Sapucaí, Pouso Alegre MG, Brazil.
,
Luisa Ribeiro Dias Godoy
1   Universidade do Vale do Sapucaí, Pouso Alegre MG, Brazil.
,
Heder Atsushi Yaguchi
1   Universidade do Vale do Sapucaí, Pouso Alegre MG, Brazil.
,
Caio Augusto de Martha Santos
1   Universidade do Vale do Sapucaí, Pouso Alegre MG, Brazil.
,
Gustavo Belani Piolli
1   Universidade do Vale do Sapucaí, Pouso Alegre MG, Brazil.
,
Julia Ribeiro Dias Godoy
1   Universidade do Vale do Sapucaí, Pouso Alegre MG, Brazil.
› Author Affiliations

*Correspondence: luisardgodoy@gmail.com.

Abstract

Case Presentation: This case is about a previously healthy 7-year-old girl who, at the age of 3 years and 5 months, presented with aphasia and motor deficit in her right upper limb, followed by gelastic seizures. Imaging tests, including a computadorized tomography, Magnetic Resonance Angiography and Angioresonance of the skull, revealed tapering of the supraclinoid portion of the internal carotid arteries, middle cerebral arteries, and initial segments of the anterior cerebral arteries, indicating Moyamoya disease and ischemic stroke. Two months later, the patient returned with sudden recurrent neurological deficits, dysphagia, sialorrhea, mental confusion, psychomotor agitation, and Broca's aphasia and was treated with diazepam and valproate. After two years, she presented with flaccidity, grade IV strength, altered tactile and painful sensibility in the left upper limb and central facial paresis on the right. She experienced a focal convulsive crisis, sialorrhea and left hemiparesis, which recurred during hospitalization and were treated with diazepam. She was diagnosed with a new ischemic stroke and aspirin was initiated.

Discussion: Moyamoya is a Japanese term meaning "puff of smoke" - a neuroimaging description of the appearance of abnormal lenticulostriate collateral vessels that results from the progressive stenosis of the intracranial internal carotid circulation that characterizes the disease. Although it has no defined etiology, it has been associated with genetic conditions, exposure to radiation, vasculitis and infection. Moyamoya syndrome is the term used when it develops secondary to an underlying disease. The main clinical manifestations include transient ischemic attack or ischemic stroke, seizures, hemiparesis, altered level of consciousness, speech and sensory disturbances. Other symptoms may include hemorrhage of the vascular neoformation and headache. According to the Suzuki staging system, the circulatory pattern seen in the patient's angioresonance would be classified as stage 3, in which there is an increase in Moyamoya vessels and stenosis of the internal carotid artery. There is no specific treatment, and management is symptomatic. Interventional treatments include surgery, direct and indirect bypass, and encephaloduroarteriosynangiosis.

Final Comments: A greater understanding of pathophysiology and scientific advances in specific treatment are essential to achieve further medical outcomes. Specialized management is necessary for patients with Moyamoya disease.



Publication History

Article published online:
12 May 2025

© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil